1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biologics Manufacturing
1.2.3 Biosimilars Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO Services Market Perspective (2017-2028)
2.2 Biopharmaceutical CMO Services Growth Trends by Region
2.2.1 Biopharmaceutical CMO Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical CMO Services Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical CMO Services Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical CMO Services Market Dynamics
2.3.1 Biopharmaceutical CMO Services Industry Trends
2.3.2 Biopharmaceutical CMO Services Market Drivers
2.3.3 Biopharmaceutical CMO Services Market Challenges
2.3.4 Biopharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO Services Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical CMO Services Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO Services Revenue
3.4 Global Biopharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO Services Revenue in 2021
3.5 Biopharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO Services Breakdown Data by Type
4.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical CMO Services Breakdown Data by Application
5.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size (2017-2028)
6.2 North America Biopharmaceutical CMO Services Market Size by Type
6.2.1 North America Biopharmaceutical CMO Services Market Size by Type (2017-2022)
6.2.2 North America Biopharmaceutical CMO Services Market Size by Type (2023-2028)
6.2.3 North America Biopharmaceutical CMO Services Market Share by Type (2017-2028)
6.3 North America Biopharmaceutical CMO Services Market Size by Application
6.3.1 North America Biopharmaceutical CMO Services Market Size by Application (2017-2022)
6.3.2 North America Biopharmaceutical CMO Services Market Size by Application (2023-2028)
6.3.3 North America Biopharmaceutical CMO Services Market Share by Application (2017-2028)
6.4 North America Biopharmaceutical CMO Services Market Size by Country
6.4.1 North America Biopharmaceutical CMO Services Market Size by Country (2017-2022)
6.4.2 North America Biopharmaceutical CMO Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size (2017-2028)
7.2 Europe Biopharmaceutical CMO Services Market Size by Type
7.2.1 Europe Biopharmaceutical CMO Services Market Size by Type (2017-2022)
7.2.2 Europe Biopharmaceutical CMO Services Market Size by Type (2023-2028)
7.2.3 Europe Biopharmaceutical CMO Services Market Share by Type (2017-2028)
7.3 Europe Biopharmaceutical CMO Services Market Size by Application
7.3.1 Europe Biopharmaceutical CMO Services Market Size by Application (2017-2022)
7.3.2 Europe Biopharmaceutical CMO Services Market Size by Application (2023-2028)
7.3.3 Europe Biopharmaceutical CMO Services Market Share by Application (2017-2028)
7.4 Europe Biopharmaceutical CMO Services Market Size by Country
7.4.1 Europe Biopharmaceutical CMO Services Market Size by Country (2017-2022)
7.4.2 Europe Biopharmaceutical CMO Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biopharmaceutical CMO Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biopharmaceutical CMO Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size (2017-2028)
9.2 Latin America Biopharmaceutical CMO Services Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO Services Market Size by Type (2017-2022)
9.2.2 Latin America Biopharmaceutical CMO Services Market Size by Type (2023-2028)
9.2.3 Latin America Biopharmaceutical CMO Services Market Share by Type (2017-2028)
9.3 Latin America Biopharmaceutical CMO Services Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO Services Market Size by Application (2017-2022)
9.3.2 Latin America Biopharmaceutical CMO Services Market Size by Application (2023-2028)
9.3.3 Latin America Biopharmaceutical CMO Services Market Share by Application (2017-2028)
9.4 Latin America Biopharmaceutical CMO Services Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO Services Market Size by Country (2017-2022)
9.4.2 Latin America Biopharmaceutical CMO Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biopharmaceutical CMO Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biopharmaceutical CMO Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO Services Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.1.5 Lonza Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 AGC Biologics
11.3.1 AGC Biologics Company Details
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics Biopharmaceutical CMO Services Introduction
11.3.4 AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.3.5 AGC Biologics Recent Developments
11.4 Rentschler Biotechnologie
11.4.1 Rentschler Biotechnologie Company Details
11.4.2 Rentschler Biotechnologie Business Overview
11.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Introduction
11.4.4 Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.4.5 Rentschler Biotechnologie Recent Developments
11.5 JRS Pharma
11.5.1 JRS Pharma Company Details
11.5.2 JRS Pharma Business Overview
11.5.3 JRS Pharma Biopharmaceutical CMO Services Introduction
11.5.4 JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.5.5 JRS Pharma Recent Developments
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Biopharmaceutical CMO Services Introduction
11.6.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.6.5 Catalent Recent Developments
11.7 Biomeva
11.7.1 Biomeva Company Details
11.7.2 Biomeva Business Overview
11.7.3 Biomeva Biopharmaceutical CMO Services Introduction
11.7.4 Biomeva Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.7.5 Biomeva Recent Developments
11.8 Samsung BioLogics
11.8.1 Samsung BioLogics Company Details
11.8.2 Samsung BioLogics Business Overview
11.8.3 Samsung BioLogics Biopharmaceutical CMO Services Introduction
11.8.4 Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.8.5 Samsung BioLogics Recent Developments
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Biopharmaceutical CMO Services Introduction
11.9.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.9.5 AbbVie Recent Developments
11.10 Binex
11.10.1 Binex Company Details
11.10.2 Binex Business Overview
11.10.3 Binex Biopharmaceutical CMO Services Introduction
11.10.4 Binex Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.10.5 Binex Recent Developments
11.11 WuXi Biologics
11.11.1 WuXi Biologics Company Details
11.11.2 WuXi Biologics Business Overview
11.11.3 WuXi Biologics Biopharmaceutical CMO Services Introduction
11.11.4 WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.11.5 WuXi Biologics Recent Developments
11.12 PRA Health Sciences
11.12.1 PRA Health Sciences Company Details
11.12.2 PRA Health Sciences Business Overview
11.12.3 PRA Health Sciences Biopharmaceutical CMO Services Introduction
11.12.4 PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.12.5 PRA Health Sciences Recent Developments
11.13 ProBioGen
11.13.1 ProBioGen Company Details
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biopharmaceutical CMO Services Introduction
11.13.4 ProBioGen Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.13.5 ProBioGen Recent Developments
11.14 KBI Biopharma
11.14.1 KBI Biopharma Company Details
11.14.2 KBI Biopharma Business Overview
11.14.3 KBI Biopharma Biopharmaceutical CMO Services Introduction
11.14.4 KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.14.5 KBI Biopharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
